Breed Distribution of the Superoxide Dismutase 1 Gene Polymorphism Associated With Degenerative Myelopathy in a Canine Population From Different Geographical Regions of Türkiye

土耳其不同地理区域犬群中与退行性脊髓病相关的超氧化物歧化酶1基因多态性的品种分布

阅读:2

Abstract

BACKGROUND AND OBJECTIVE: Canine degenerative myelopathy (CDM) is a progressive neurodegenerative condition that impacts the spinal cord, resulting in paralysis in dogs. CDM is linked to a missense mutation in the superoxide dismutase 1 (SOD1) gene. This study aimed to examine the presence of the SOD1:c.118G>A mutation in the German Shepherd, Golden Retriever, Pomeranian, Toy Poodle and native Kangal Shepherd dog breeds in Türkiye. METHODS: Blood samples (n = 161) from five breeds, collected from six provinces across five geographic regions of Türkiye, were tested for the prevalence of the mutant allele associated with CDM. All dogs were clinically healthy and sampled for genetic testing. Genotyping was performed using the PCR-RFLP method and gel electrophoresis. RESULTS: Genotyping of dogs revealed that 141 had the homozygous wild-type genotype (GG), 20 were heterozygous carriers (AG), and there were no homozygous mutant (AA) individuals. The mutant A allele was determined in Kangal Shepherd, German Shepherd and Toy Poodle dog breeds. The frequency of the mutant allele in the investigated population was identified as 0.062. It was determined that the mutant allele, which was not previously reported in the Kangal Shepherds, was present, and the mutant allele frequency revealed 0.057. CONCLUSIONS: The SOD1:c.118G>A mutation is present in dog breeds in Türkiye, and is also detected in the Kangal Shepherd, an ancient breed. This finding underscores the importance of genetic testing in dogs, as it is crucial to prevent the spread of mutations in different canine populations. Carrier dogs can be clinically identified to prevent breeding and reduce CDM incidence.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。